Edwards Lifesciences (NYSE: EW) net income
Edwards Lifesciences reported a net profit of $1,074m for fiscal 2025, 74.3% less than in fiscal 2024 ($4,175m). Its net margin was 17.7%. Earnings per share were $1.84.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $1,074m | −74.3% | 17.7% | $1.84 |
| 2024 | $4,175m | +197.7% | 76.7% | $6.98 |
| 2023 | $1,402m | −7.9% | 28.0% | $2.31 |
| 2022 | $1,522m | +1.3% | 34.1% | $2.46 |
| 2021 | $1,503m | +82.5% | 28.7% | $2.41 |
| 2020 | $823.4m | −21.3% | 18.8% | $1.32 |
| 2019 | $1,047m | +45.0% | 24.1% | $5.03 |
| 2018 | $722.2m | +23.7% | 19.4% | $3.45 |
| 2017 | $583.6m | +2.5% | 17.0% | $2.77 |
| 2016 | $569.5m | — | 19.2% | $2.67 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Edwards Lifesciences
- How much did Edwards Lifesciences earn in fiscal 2025?
- Edwards Lifesciences reported a net profit of $1,074m for fiscal 2025. In fiscal 2024 it reported a net profit of $4,175m.
- What are the earnings per share of Edwards Lifesciences?
- They were $1.84 in fiscal 2025, compared with $6.98 in fiscal 2024.
- What is the net margin of Edwards Lifesciences?
- In fiscal 2025 its net profit was 17.7% of its revenue.
- What was the most profitable year for Edwards Lifesciences?
- Of its last 10 fiscal years, fiscal 2024, with $4,175m.
- Where do the figures for Edwards Lifesciences come from?
- From the annual report (Form 10-K) that Edwards Lifesciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Edwards Lifesciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Edwards Lifesciences: the Edwards Lifesciences page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.